Department of Internal Medicine, Soonchunhyang University School of Medicine, Asan, Korea.
Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.
Gut Liver. 2024 Jul 15;18(4):695-708. doi: 10.5009/gnl230485. Epub 2024 May 7.
BACKGROUND/AIMS: : With increased life expectancy, the management of elderly hepatocellular carcinoma (HCC) patients became a crucial issue, yet it is still challenging due to comorbidities and high surgical risks. While surgical resection is considered as primary treatment for eligible HCC patients, systematic evidence on its outcomes in elderly patients remains scarce. In this review, we aimed to analyze the efficacy and safety outcomes of surgical resection in elderly HCC patients.
: The studies included in this meta-analysis were selected from Ovid-MEDLINE, Ovid-Embase, CENTRAL, KoreaMed, KMbase, and KISS databases following a predefined protocol. Efficacy outcomes included overall survival and disease-free survival, while the safety outcomes included postoperative mortality and complications.
: Patients in the elderly group (≥65 years) who underwent surgery exhibited non-inferior overall survival (hazard ratio [HR], 1.26; 95% confidence interval [CI], 0.92 to 1.74) and disease-free survival (HR, 1.03; 95% CI, 0.99 to 1.08) compared to the non-elderly group. Overall postoperative mortality exhibited no statistical difference (odds ratio [OR], 1.07; 95% CI, 0.87 to 1.31), but 30-day, 90-day, and in-hospital mortality were higher in the elderly group. The incidence of overall complications was higher in the elderly group (OR, 1.44; 95% CI, 1.22 to 1.69). Sensitivity analysis for the super elderly group (≥80 years) showed significantly higher in-hospital mortality compared to the non-super elderly group (OR, 2.51; 95% CI, 1.16 to 5.45).
: The efficacy outcome of surgical resection in the elderly HCC patients was not worse than that in the non-elderly HCC patients, while in-hospital mortality and complications rates were higher. Therefore, surgical resection should be purposefully considered in the elderly population, with careful candidate selection.
背景/目的:随着预期寿命的延长,老年肝细胞癌(HCC)患者的管理成为一个关键问题,但由于合并症和高手术风险,这仍然具有挑战性。虽然手术切除被认为是适合 HCC 患者的主要治疗方法,但关于老年患者手术切除效果的系统证据仍然很少。在本综述中,我们旨在分析手术切除治疗老年 HCC 患者的疗效和安全性结局。
本荟萃分析纳入的研究均按照预先制定的方案,从 Ovid-MEDLINE、Ovid-Embase、CENTRAL、韩国医学文献数据库(KoreaMed)、KMbase 和 KISS 数据库中筛选。疗效结局包括总生存率和无疾病生存率,安全性结局包括术后死亡率和并发症。
与非老年组相比,接受手术的老年组(≥65 岁)患者的总生存率(风险比 [HR],1.26;95%置信区间 [CI],0.92 至 1.74)和无疾病生存率(HR,1.03;95%CI,0.99 至 1.08)无明显差异。总体术后死亡率无统计学差异(比值比 [OR],1.07;95%CI,0.87 至 1.31),但老年组的 30 天、90 天和住院死亡率更高。老年组的总并发症发生率更高(OR,1.44;95%CI,1.22 至 1.69)。对超高龄组(≥80 岁)的敏感性分析显示,与非超高龄组相比,住院死亡率明显更高(OR,2.51;95%CI,1.16 至 5.45)。
手术切除治疗老年 HCC 患者的疗效并不逊于非老年 HCC 患者,但住院死亡率和并发症发生率较高。因此,应在老年人群中慎重考虑手术切除,并进行仔细的候选者选择。